Obesity. Obesity
Conditions
Interventions
Intervention 1: The Intervention group will receive daily dose of 30 grams of oxymel whose volume is raised to 250 cc by adding water for 30 days. Intervention 2: The control group will receive daily
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: 20 to 50 years people Body mass index equal to or greater than 25 kg/m2 No history of allergy to vinegar and oxymel No digestive problems such as reflux and stomach problems No lung diseases, especially cough Not using of blood glucose lowering medicines, lipid lowering medicines, blood pressure lowering medicines and appetite stimulant medicines No common (daily) usage of oxymel and vinegar Not using of drugs and alcohol No pregnancy and lactation
Exclusion criteria
Exclusion criteria: Unwillingness of individuals to cooperate with the study procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of serum total cholesterol (TC). Timepoint: Measurement of serum total cholesterol will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Serum total cholesterol will be measured by enzymatic method using Autoanalyzer.;Reduction of serum low density lipoprotein cholesterol (LDL-C). Timepoint: Measurement of serum low density lipoprotein cholesterol will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Serum low density lipoprotein cholesterol will be calculated by Friedewald formula (LDL-C = TC - (HDL-C + TG/5).;Reduction of triglycerides. Timepoint: Measurement of serum triglycerides will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Serum triglycerides will be measured by enzymatic method using Autoanalyzer.;Enhancement of serum high density lipoprotein cholesterol (HDL-C). Timepoint: Measurement of serum high density lipoprotein cholesterol will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Serum high density lipoprotein cholesterol will be measured by enzymatic method using Autoanalyzer.;Reduction of blood glucose level. Timepoint: Measurement of blood glucose level will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Blood glucose level will be measured by enzymatic method using Autoanalyzer.;Reduction of systolic and diastolic blood pressure. Timepoint: Measurement of systolic and diastolic blood pressure will be made before receiving oxymel and after receiving it for 30 days. Method of measurement: Systolic and diastolic blood pressure will be measured will be measured by a digital sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Body mass index will be measured before intervention and after intervention for 30 days. Method of measurement: body mass index (BMI) is calculated as weight (kg) divided by height squared (m2).;Reduction of waist circumference. Timepoint: Measurement of waist circumference will be made before intervention and after intervention for 30 days. Method of measurement: tape measure.;Reduction of hip circumference. Timepoint: Measurement of hip circumference will be made before intervention and after intervention for 30 days. Method of measurement: tape measure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShirin Parvinroo
Rasht University of Medical Sciences
Outcome results
None listed